JELMYTO
Drug
UROGEN PHARMA, INC.
Total Payments
$2.3M
Transactions
23,369
Doctors
7,064
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $758,821 | 7,691 | 3,977 |
| 2023 | $524,727 | 6,429 | 3,453 |
| 2022 | $361,889 | 5,248 | 2,786 |
| 2021 | $581,852 | 3,370 | 1,800 |
| 2020 | $82,474 | 631 | 471 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $824,374 | 239 | 35.7% |
| Food and Beverage | $720,297 | 22,210 | 31.2% |
| Consulting Fee | $392,618 | 133 | 17.0% |
| Unspecified | $228,408 | 85 | 9.9% |
| Travel and Lodging | $96,330 | 315 | 4.2% |
| Gift | $23,094 | 45 | 1.0% |
| Space rental or facility fees (teaching hospital only) | $18,500 | 6 | 0.8% |
| Education | $3,742 | 335 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,400 | 1 | 0.1% |
Payments by Type
General
$2.1M
23,284 transactions
Research
$228,408
85 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| UTRACT JELMYTO REGISTRY - A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER (UTUC) TREATED WITH JELMYTO (UTRACT) | UROGEN PHARMA, INC. | $103,594 | 3 |
| UTRACT JELMYTO REGISTRY A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER UTUC TREATED WITH JELMYTO UTRACT | UROGEN PHARMA, INC. | $96,448 | 0 |
| OLYMPUS | UROGEN PHARMA, INC. | $19,214 | 0 |
| OLYMPUS FINAL MANUSCRIPT | UROGEN PHARMA, INC. | $9,152 | 26 |
Top Doctors Receiving Payments for JELMYTO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , D.O | Urology | Columbia, MO | $327,371 | 329 |
| Unknown | — | Boston, MA | $240,741 | 112 |
| , M.D | Surgical Oncology | Los Angeles, CA | $108,327 | 24 |
| , M.D | Urology | Johns Creek, GA | $88,981 | 112 |
| , M.D | Urology | Santa Monica, CA | $62,931 | 51 |
| , M.D | Urology | Hackensack, NJ | $58,139 | 51 |
| , MD, MPHIL | Urology | Charleston, SC | $57,659 | 61 |
| , MD | Urology | Dallas, TX | $43,995 | 26 |
| Alan Nieder | Urology | Miami Beach, FL | $32,427 | 64 |
| , M.D | Urology | Iowa City, IA | $29,619 | 32 |
| , M.D | Urology | Augusta, GA | $23,620 | 23 |
| , MD | Urology | Hanover, MD | $23,561 | 27 |
| , MD | Urology | Loma Linda, CA | $21,560 | 24 |
| , MD | Urology | Dallas, TX | $20,931 | 28 |
| , MD | Urology | West Bloomfield, MI | $19,969 | 26 |
| , M.D | Urology | Dallas, TX | $19,186 | 17 |
| , MD | Urology | Knoxville, TN | $18,578 | 34 |
| , MD02041967 | Urology | Philadelphia, PA | $18,041 | 12 |
| , MD | Urology | Boston, MA | $17,781 | 10 |
| , M.D | Urology | Hershey, PA | $14,038 | 19 |
| , MD, PHD | Urology | Chicago, IL | $13,676 | 5 |
| , M.D | Urology | Los Angeles, CA | $13,092 | 11 |
| , DO | Urology | Chapel Hill, NC | $12,602 | 11 |
| , MD | Urology | Iowa City, IA | $11,569 | 14 |
| , MD | Urology | Cincinnati, OH | $11,451 | 39 |
Ad
Manufacturing Companies
- UROGEN PHARMA, INC. $1.5M
- UroGen Pharma, Inc. $783,080
Product Information
- Type Drug
- Total Payments $2.3M
- Total Doctors 7,064
- Transactions 23,369
About JELMYTO
JELMYTO is a drug associated with $2.3M in payments to 7,064 healthcare providers, recorded across 23,369 transactions in the CMS Open Payments database. The primary manufacturer is UROGEN PHARMA, INC..
Payment data is available from 2020 to 2024. In 2024, $758,821 was paid across 7,691 transactions to 3,977 doctors.
The most common payment nature for JELMYTO is "Honoraria" ($824,374, 35.7% of total).
JELMYTO is associated with 4 research studies, including "UTRACT JELMYTO REGISTRY - A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER (UTUC) TREATED WITH JELMYTO (UTRACT)" ($103,594).